232 related articles for article (PubMed ID: 34360581)
1. The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H
Pomierny B; Krzyżanowska W; Jurczyk J; Skórkowska A; Strach B; Szafarz M; Przejczowska-Pomierny K; Torregrossa R; Whiteman M; Marcinkowska M; Pera J; Budziszewska B
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360581
[TBL] [Abstract][Full Text] [Related]
2. AP39, A Mitochondrially Targeted Hydrogen Sulfide Donor, Exerts Protective Effects in Renal Epithelial Cells Subjected to Oxidative Stress in Vitro and in Acute Renal Injury in Vivo.
Ahmad A; Olah G; Szczesny B; Wood ME; Whiteman M; Szabo C
Shock; 2016 Jan; 45(1):88-97. PubMed ID: 26513708
[TBL] [Abstract][Full Text] [Related]
3. Both the H
Ahmad A; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):348-355. PubMed ID: 27639598
[TBL] [Abstract][Full Text] [Related]
4. The novel mitochondria-targeted hydrogen sulfide (H
Gerő D; Torregrossa R; Perry A; Waters A; Le-Trionnaire S; Whatmore JL; Wood M; Whiteman M
Pharmacol Res; 2016 Nov; 113(Pt A):186-198. PubMed ID: 27565382
[TBL] [Abstract][Full Text] [Related]
5. The Hydrogen Sulfide Donor AP39 Reduces Glutamate-mediated Excitotoxicity in a Rat Model of Brain Ischemia.
Skórkowska A; Krzyżanowska W; Bystrowska B; Torregrossa R; Whiteman M; Pomierny B; Budziszewska B
Neuroscience; 2024 Feb; 539():86-102. PubMed ID: 37993086
[TBL] [Abstract][Full Text] [Related]
6. AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons.
Zhao FL; Fang F; Qiao PF; Yan N; Gao D; Yan Y
Oxid Med Cell Longev; 2016; 2016():8360738. PubMed ID: 27057285
[TBL] [Abstract][Full Text] [Related]
7. AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.
Szczesny B; Módis K; Yanagi K; Coletta C; Le Trionnaire S; Perry A; Wood ME; Whiteman M; Szabo C
Nitric Oxide; 2014 Sep; 41():120-30. PubMed ID: 24755204
[TBL] [Abstract][Full Text] [Related]
8. The mitochondria-targeted hydrogen sulfide donor AP39 improves health and mitochondrial function in a C. elegans primary mitochondrial disease model.
Fox BC; Slade L; Torregrossa R; Pacitti D; Szabo C; Etheridge T; Whiteman M
J Inherit Metab Dis; 2021 Mar; 44(2):367-375. PubMed ID: 33325042
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia.
Wang Y; Jia J; Ao G; Hu L; Liu H; Xiao Y; Du H; Alkayed NJ; Liu CF; Cheng J
J Neurochem; 2014 Jun; 129(5):827-38. PubMed ID: 24673410
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria-targeted hydrogen sulfide donors versus acute oxidative gastric mucosal injury.
Magierowska K; Korbut E; Wójcik-Grzybek D; Bakalarz D; Sliwowski Z; Cieszkowski J; Szetela M; Torregrossa R; Whiteman M; Magierowski M
J Control Release; 2022 Aug; 348():321-334. PubMed ID: 35654168
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeted hydrogen sulfide donor AP39 improves neurological outcomes after cardiac arrest in mice.
Ikeda K; Marutani E; Hirai S; Wood ME; Whiteman M; Ichinose F
Nitric Oxide; 2015 Sep; 49():90-6. PubMed ID: 25960429
[TBL] [Abstract][Full Text] [Related]
12. Supplementing preservation solution with mitochondria-targeted H
Zhu C; Su Y; Juriasingani S; Zheng H; Veramkovich V; Jiang J; Sener A; Whiteman M; Lacefield J; Nagpal D; Alotaibi F; Liu K; Zheng X
Am J Transplant; 2019 Nov; 19(11):3139-3148. PubMed ID: 31338943
[TBL] [Abstract][Full Text] [Related]
13. AP39 ameliorates high fat diet-induced liver injury in young rats via alleviation of oxidative stress and mitochondrial impairment.
Yu Y; Ye SM; Liu DY; Yang LQ
Exp Anim; 2021 Nov; 70(4):553-562. PubMed ID: 34305077
[TBL] [Abstract][Full Text] [Related]
14. AP39, a mitochondria-targeting hydrogen sulfide (H
Karwi QG; Bornbaum J; Boengler K; Torregrossa R; Whiteman M; Wood ME; Schulz R; Baxter GF
Br J Pharmacol; 2017 Feb; 174(4):287-301. PubMed ID: 27930802
[TBL] [Abstract][Full Text] [Related]
15. The Mitochondria-Targeted H2S-Donor AP39 in a Murine Model of Combined Hemorrhagic Shock and Blunt Chest Trauma.
Wepler M; Merz T; Wachter U; Vogt J; Calzia E; Scheuerle A; Möller P; Gröger M; Kress S; Fink M; Lukaschewski B; Rumm G; Stahl B; Georgieff M; Huber-Lang M; Torregrossa R; Whiteman M; McCook O; Radermacher P; Hartmann C
Shock; 2019 Aug; 52(2):230-239. PubMed ID: 29927788
[TBL] [Abstract][Full Text] [Related]
16. The cystathionine β-synthase/hydrogen sulfide pathway contributes to microglia-mediated neuroinflammation following cerebral ischemia.
Zhang M; Wu X; Xu Y; He M; Yang J; Li J; Li Y; Ao G; Cheng J; Jia J
Brain Behav Immun; 2017 Nov; 66():332-346. PubMed ID: 28751019
[TBL] [Abstract][Full Text] [Related]
17. Vasorelaxant Activity of AP39, a Mitochondria-Targeted H
da Costa Marques LA; Teixeira SA; de Jesus FN; Wood ME; Torregrossa R; Whiteman M; Costa SKP; Muscará MN
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204781
[TBL] [Abstract][Full Text] [Related]
18. Novel controlled and targeted releasing hydrogen sulfide system exerts combinational cerebral and myocardial protection after cardiac arrest.
Sun X; Wang Y; Wen S; Huang K; Huang J; Chu X; Wang F; Pang L
J Nanobiotechnology; 2021 Feb; 19(1):40. PubMed ID: 33549092
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria-targeted hydrogen sulfide attenuates endothelial senescence by selective induction of splicing factors
Latorre E; Torregrossa R; Wood ME; Whiteman M; Harries LW
Aging (Albany NY); 2018 Jul; 10(7):1666-1681. PubMed ID: 30026406
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide is a mediator of cerebral ischemic damage.
Qu K; Chen CP; Halliwell B; Moore PK; Wong PT
Stroke; 2006 Mar; 37(3):889-93. PubMed ID: 16439695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
